Comphya
Headquarters
Rte Cantonale, 1015 Lausanne, Switzerland
Industry
HealthTech
Website
About us
Comphya is developing an active implantable medical device to restore the erectile function of patient non-responsive to oral drugs (e.g. Viagra or Cialis). To achieve erection, these patients have to resort to intrapenial injections of vasodilators or penile implants, which are quite problematic and outdated. Thus, there is a clear need for better modalities for these patients. Comphya's main focus is spinal cord injury (SCI) and prostatectomy patients.
Organization size
1-10 employees
Wanted occupations
Wanted field of studies
Funding stage
Private